Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...
BANDUNG, itb.ac.id - The PINTAR Diagnostics team from the School of Life Sciences and Technology (SLST), Institut Teknologi ...
React4Life’s Silvia Scaglione emphasizes how organ-on-chip tech and AI are reshaping drug testing, personalized treatment, ...
DeePFAS, a novel deep-learning model, streamlines large-scale non-targeted screening of "forever chemicals" (PFAS) by ...
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine ...
Manuscript Summary Submission Deadline 30 November 2025 | Manuscript Submission Deadline 20 March 2026 ...
Vaccine against stomach ulcers? You read it right. Painful stomach ulcers may soon be a thing of the past, thanks to Ateneo de Manila University scientists who are doing a research to prevent the ...
11d
What Will Define the Future of Pharma? Five Trends on Solvias' Radar Ahead of CPHI Frankfurt 2025
CPHI Frankfurt, one of the world's largest gatherings for the pharmaceutical industry, is where the latest science, ...
This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback